Samantha Semenkow Analyst PerformanceAnalyst at CitigroupSamantha Semenkow is a stock analyst at Citigroup focused in the medical sector, covering 19 publicly traded companies. Over the past year, Samantha Semenkow has issued 43 stock ratings, including buy, hold, and sell recommendations. While full access to Samantha Semenkow's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Samantha Semenkow's coverage history, rating activity, and performance tendencies — helping individual investors make more informed trading decisions. Analyst Rankings, Coverage, and Performance StatisticsAnalyst RankingSubscribe to MarketBeat All Access for the analyst's recommendation accuracy rating MarketBeatAverage Return00.00% 12-Month ROISuccess Rate00.00% Profitable RatingsTotal Ratings45 Last 1 YearsBuy Recommendations86.67% 39 Buy RatingsCompanies Covered19 Unique Companies Ratings Distribution45RatingsDistribution of strong buy, buy, hold, and sell ratings by Samantha Semenkow.RatingPercentageCount Strong Buy0.0%0 ratings Buy86.7%39 ratings Hold11.1%5 ratings Sell2.2%1 ratingsOut of 45 total stock ratings issued by Samantha Semenkow at Citigroup, the majority (86.7%) have been Buy recommendations, followed by 11.1% Hold and 2.2% Sell.Best & Worst CallsBest Call000.0%GPCRMay 2025Subscribe to MarketBeat All Access to get analyst recommendation ROI.Worst Call000.0%ARGXApr 2025Subscribe to MarketBeat All Access to get analyst recommendation ROI.Exchange CoverageExchangePercentageCountNASDAQ94.7% of companies on NASDAQ18 companiesNYSE5.3% of companies on NYSE1 companySamantha Semenkow, an analyst at Citigroup, currently covers 19 companies listed on NASDAQ and NYSE, with the majority traded on NASDAQ.Coverage FocusSector IconSectorPercentageMedical17 companies89.5%Manufacturing2 companies10.5%Samantha Semenkow of Citigroup specializes in stock coverage within the Medical sector, with additional focus on Manufacturing companies.Coverage IndustriesIndustryPercentageMED - BIOMED/GENE14 companies73.7%MED - DRUGS3 companies15.8%Miscellaneous1 company5.3%BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES1 company5.3% Samantha Semenkow's Ratings History at Citigroup Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 4 Years 5 Years All Time Timeframe Start Date End Date All Ratings Strong Buy Buy Hold Sell Rating Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.Available with a MarketBeat All Access Subscription12-Month ROIUpgrade to All Access to use the All ROI Filter Export CompanyReport DateActionReport Date Price12-MonthPrice TargetRating12-MonthPrice & ROIDetailsWVEWAVE Life Sciences5/4/2026Lower Price Target$7.32$24.00Buy$0.0000.00% ROINKTRNektar Therapeutics4/21/2026Boost Price Target$98.32$151.00Buy$0.0000.00% ROIBHVNBiohaven4/2/2026Boost Price Target$9.84$17.00Buy$0.0000.00% ROIBEAMBeam Therapeutics3/26/2026Boost Price Target$23.74$68.00Buy$0.0000.00% ROIRYTMRhythm Pharmaceuticals3/17/2026Lower Price Target$89.62$131.00Buy$0.0000.00% ROINKTRNektar Therapeutics3/16/2026Boost Price Target$73.91$123.00Buy$0.0000.00% ROIBIOABioAge Labs3/10/2026Boost Price Target$20.91$52.00Buy$0.0000.00% ROIAGIOAgios Pharmaceuticals3/5/2026Boost Price Target$28.07$46.00Buy$0.0000.00% ROICPRXCatalyst Pharmaceuticals3/3/2026Boost Price Target$23.78$35.00Buy$0.0000.00% ROILRMRLarimar Therapeutics2/25/2026Boost Price Target$6.23$14.00Buy$0.0000.00% ROI Get the Latest News and Ratings for Your StocksEnter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter. CGEMCullinan Therapeutics2/17/2026Initiated Coverage$11.59$33.00Buy$0.0000.00% ROICGEMCullinan Therapeutics2/17/2026Initiated Coverage$12.44$33.00Buy$0.0000.00% ROIROIVRoivant Sciences2/10/2026Boost Price Target$27.67$35.00Buy$0.0000.00% ROIARGXargenex1/8/2026Lower Price Target$796.37$1,091.00Buy$0.0000.00% ROIAGIOAgios Pharmaceuticals12/26/2025Reiterated Rating$28.90Buy$0.0000.00% ROIBHVNBiohaven12/26/2025Reiterated Rating$9.06Buy$0.0000.00% ROIFOLDAmicus Therapeutics12/22/2025Reiterated Rating$14.20$14.50Neutral$0.0000.00% ROIFOLDAmicus Therapeutics12/21/2025Downgrade$14.21Hold$0.0000.00% ROISYRESpyre Therapeutics12/17/2025Initiated Coverage$32.97$64.00Buy$0.0000.00% ROIFOLDAmicus Therapeutics12/17/2025Initiated Coverage$10.89$17.00Buy$0.0000.00% ROIGPCRStructure Therapeutics12/12/2025Reiterated Rating$67.44Outperform$0.0000.00% ROIRYTMRhythm Pharmaceuticals12/12/2025Reiterated Rating$117.62Outperform$0.0000.00% ROIWVEWAVE Life Sciences12/9/2025Boost Price Target$18.52$30.00Buy$0.0000.00% ROIGPCRStructure Therapeutics12/9/2025Boost Price Target$69.98$100.00Buy$0.0000.00% ROIAGIOAgios Pharmaceuticals11/26/2025Initiated Coverage$28.42$38.00Buy$0.0000.00% ROINKTRNektar Therapeutics11/26/2025Initiated Coverage$60.35$102.00Buy$0.0000.00% ROIRYTMRhythm Pharmaceuticals11/25/2025Initiated Coverage$106.58$136.00Buy$0.0000.00% ROIARGXargenex11/17/2025Boost Price Target$920.78$1,124.00Buy$0.0000.00% ROIBHVNBiohaven11/13/2025Lower Price Target$8.10$14.00Buy$0.0000.00% ROIPRMEPrime Medicine11/11/2025Lower Price Target$3.81$4.25Neutral$0.0000.00% ROIROIVRoivant Sciences11/11/2025Boost Price Target$20.89$26.00Buy$0.0000.00% ROICPRXCatalyst Pharmaceuticals11/7/2025Boost Price Target$21.36$33.00Buy$0.0000.00% ROIROIVRoivant Sciences10/29/2025Boost Price Target$18.43$25.00Buy$0.0000.00% ROIBIOABioAge Labs10/29/2025Boost Price Target$7.88$15.00Buy$0.0000.00% ROIMLTXMoonLake Immunotherapeutics10/29/2025Downgrade$9.79Sell$0.0000.00% ROIMLTXMoonLake Immunotherapeutics9/30/2025Downgrade$6.24Neutral$0.0000.00% ROIBHVNBiohaven9/17/2025Initiated Coverage$13.52$28.00Buy$0.0000.00% ROIROIVRoivant Sciences9/2/2025Initiated Coverage$11.93$16.00Buy$0.0000.00% ROIWVEWAVE Life Sciences7/16/2025Initiated Coverage$7.71$16.00Buy$0.0000.00% ROIPRMEPrime Medicine5/27/2025Reiterated Rating$1.29$1.50Neutral$0.0000.00% ROICABACabaletta Bio5/16/2025Lower Price Target$1.77$13.00Buy$0.0000.00% ROIALLOAllogene Therapeutics5/15/2025Lower Price Target$1.07$4.00Buy$0.0000.00% ROIARGXargenex5/9/2025Boost Price Target$567.57$803.00Buy$0.0000.00% ROIGPCRStructure Therapeutics5/2/2025Initiated Coverage$27.33$60.00Buy$00.0000.00% ROIARGXargenex4/17/2025Boost Price Target$594.76$796.00Buy$000.0000.00% ROI Stock Forecasts and Research Tools Today's Analyst Ratings U.S. Ratings U.K. Ratings Canadian Ratings All Upgrades All Downgrades All Initiations All Price Target Changes Top-Rated Stocks Top Rated Stocks Top-Rated Dividend Stocks Top-Rated Small-Cap Stocks Top-Rated Tech Stocks Most-Upgraded Stocks Most-Downgraded Stocks Lowest-Rated Stocks More Ratings Tools Stock Ratings by Issuer Top-Rated Analysts Top-Rated Brokerages Stock Ratings Screener Free Ratings Newsletter Price Forecasts for Popular Stocks Alphabet (Google) Stock ForecastAmazon Stock ForecastApple Stock ForecastMeta (Facebook) Stock ForecastMicrosoft Stock ForecastNetflix Stock ForecastNvidia Stock ForecastTesla Stock Forecast Top Stock Recommendations by BrokerageWall Street ZenUBS GroupCitigroupBarclaysMorgan StanleyWells Fargo & CompanyRoyal Bank Of CanadaJPMorgan Chase & Co.Jefferies Financial GroupThe Goldman Sachs GroupTruist FinancialTD CowenPiper SandlerRaymond James FinancialStifel Nicolaus Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
